PTAB Upholds Biogen Drug Patent In Hedge Fund Challenge
The Patent Trial and Appeal Board on Tuesday upheld a Biogen patent covering multiple sclerosis drug Tecfidera in an inter partes review requested by the Coalition for Affordable Drugs, a group...To view the full article, register now.
Already a subscriber? Click here to view full article